Patents
Patents for C07K 2 - Peptides of undefined number of amino acids; Derivatives thereof (4,723)
06/2005
06/09/2005WO2005037859A9 Fluorescence assay for kinase activity
06/07/2005US6903199 Crosslinked amide derivatives of hyaluronic acid and manufacturing method thereof
06/02/2005WO2005018575A3 Estrogen receptor modulators and uses thereof
06/02/2005WO2004112572A3 Monitoring immunologic, hematologic and inflammatory diseases
06/02/2005WO2004071414A3 Therapeutic anti-hcv (al9) compounds
06/02/2005WO2004065547A3 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
06/01/2005EP1534718A1 Chemical synthesis of reagents for peptide coupling
06/01/2005CN1203847C Chemically-defined non-polymeric valency plateform molecules and conjugates thereof
05/2005
05/31/2005US6900293 Monoclonal antibodies directed against the microtubule-associated protein tau
05/26/2005WO2005009363A3 Treatment of pre-cancerous conditions and prevention of cancer using pcdgf-based therapies
05/26/2005WO2005009217A3 Diagnosis of pre-cancerous conditions using pcdgf agents
05/26/2005WO2004080412A3 Paclitaxel hybrid derivatives
05/26/2005US20050114035 Method for binding site identification
05/26/2005CA2545187A1 Vegf receptor antagonists
05/25/2005CN1203179C DNA sequence and recombination production method of graminae allergen
05/19/2005WO2004110367A3 Sdr proteins from staphylococcus capitis and their use in preventing and treating infections
05/18/2005EP1530638A2 T-cell epitopes in staphylococcal enterotoxin b
05/18/2005CN1202130C Solid, stable and concentrated type ortho-silicis acid complex based on bio-absorption, and its prepn. method
05/12/2005WO2004103270A3 Compounds and methods for treatment of thrombosis
05/12/2005WO2003022126A3 Compositions and methods for the therapy and diagnosis of colon cancer
05/06/2005WO2004094644A3 Vibrio cholerae proteins expressed during infection
05/05/2005US20050096457 Peptide substrates and fusion polypeptide substrates comprising a beta -secretase cleavage site wherein a human Aspartyl protease cleaves the peptide between P1 and P1, the rate of which cleavage is used to identify modulators of Alzeimer's disease, neurofibrillary tangles, gliosis and neuronal loss
05/05/2005US20050096456 Compounds comprising pseudo-amino acids
05/05/2005US20050095241 Estrogen receptor modulators and uses thereof
05/04/2005CN1612896A Peptide purification by means of metal ion affinity chromatography
04/2005
04/28/2005WO2005037859A2 Fluorescence assay for kinase activity
04/28/2005WO2004110390A3 Anti-cd74 immunoconjugates and methods
04/21/2005CA2578473A1 Peptide nucleic acid conjugates and uses thereof
04/14/2005WO2005032491A2 Methods and compositions for mycoplasma pneumoniae exotoxins
04/14/2005WO2005032461A2 Novel peptide with osteogenic activity
04/14/2005WO2004072105A3 Iap-binding cargo molecules and peptidomimetics for use in diagnostic and therapeutic methods
04/14/2005US20050080243 Screening for enzyme inhibitors; signal transduction passageways' chelation enhancement fluorescence
04/14/2005US20050080242 Fluorescence assay for kinase activity
04/14/2005CA2541018A1 Human prostate cancer cell factor(s) that induce stem cell commitment and osteogenesis
04/14/2005CA2540703A1 Methods and compositions for mycoplasma pneumoniae exotoxins
04/13/2005EP1522582A2 Optical sorting method
04/13/2005EP1522581A2 Optical sortingmethod
04/07/2005WO2004094600A3 Staphylococcus aureus efb protein and c3 binding region which inhibit complement activation
04/06/2005CN1604910A Affinity enhancement agents
04/05/2005US6875749 Methods of facilitating vascular growth
04/05/2005US6875616 Process for determining the status of an organism by peptide measurement
03/2005
03/30/2005CN1602204A Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies
03/29/2005US6872520 Peptide for use in the detection of viral infection and diseases
03/24/2005WO2004108747A3 Lectin conjugates
03/24/2005WO2004103266A3 Protein kinase c peptides for use in withdrawal
03/24/2005WO2004065409A3 Peptide mimotopes of lipooligosaccharide from nontypeable haemophilus influenzae as vaccines
03/24/2005US20050064410 Method and nucleic acids for the analysis of colon cancer
03/24/2005US20050063986 Process for the preparation of non-toxic anthrax vaccine
03/23/2005CN1597953A Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies
03/23/2005CN1193788C Beta 2-adrenergic receptor agonist
03/22/2005CA2142638C Antibiotic wap-8294a, method for preparing the same and antibacterial composition
03/17/2005CA2579635A1 Peptides that inhibit complement activation
03/17/2005CA2537798A1 Cytidine deaminase activators, deoxycytidine deaminase activators, vif antagonists, and methods of screening for molecules thereof
03/16/2005EP1514114A2 Method to screen ligands using eukaryotic cell display
03/16/2005CN1594357A Immune regulatory gene extracting method and use in preparation of drug for treating barrenness
03/09/2005CN1590404A Antigenic meningococcal peptides
03/03/2005WO2005018575A2 Estrogen receptor modulators and uses thereof
03/03/2005CA2536946A1 Estrogen receptor modulators and uses thereof
03/02/2005EP1509768A2 Methods for cohort selection and longevity studies
02/2005
02/24/2005WO2005016244A2 Methods and compositions for the treatment of gastrointestinal disorders
02/24/2005US20050042602 Monitoring immunologic, Hematologic and inflammatory diseases
02/24/2005CA2529307A1 Methods and compositions for the treatment of gastrointestinal disorders
02/23/2005EP1507804A1 Active carbohydrate containing protecting reagents for chemical modifications, their production and use
02/23/2005CN1585776A Detection and identification of enteric bacteria
02/17/2005US20050037392 Optical sorting method
02/17/2005US20050037334 Method of determining sperm capacitation
02/17/2005CA2534412A1 Conjugates of a polymer and a protein linked by an oxime linking group
02/10/2005WO2005011607A2 Treatment of cancers expressing p95 erbb2
02/09/2005EP1503749A2 Methionine aminopeptidase-2 inhibitors and methods of use thereof
02/03/2005WO2005009396A2 Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections
02/03/2005WO2005009378A2 Polypeptides for inducing a protective immune response against staphylococcus aureus
02/03/2005WO2005009363A2 Treatment of pre-cancerous conditions and prevention of cancer using pcdgf-based therapies
02/03/2005WO2005009222A2 Method of determining sperm capacitation
02/03/2005WO2005009217A2 Diagnosis of pre-cancerous conditions using pcdgf agents
02/03/2005CA2533542A1 Method of determining sperm capacitation
02/03/2005CA2517600A1 Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections
02/02/2005EP0761683B1 Protein or polypeptide, process for producing the same, and intermediate compound tehrefor
02/02/2005CN1572797A Chemically-defined non-polymeric valency platform molecules and conjugates thereof
02/01/2005US6849458 Microplate thermal shift assay apparatus for ligand development and multi-variable protein chemistry optimization
01/2005
01/27/2005WO2005007680A1 Arginine/lysine-enriched peptides
01/25/2005CA2308292C Method of dna shuffling
01/20/2005US20050014718 Tumor specific oligosaccharide sequences and use thereof
01/19/2005EP1496878A1 Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds
01/19/2005CN1565627A Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation
01/12/2005CN1184230C Antifungal albumen
01/11/2005US6841689 Process using catalyst comprising soluble polymer and polymino acid
01/06/2005US20050003345 Synthetic antigens for the detection of antibodies to hepatitis C virus
01/06/2005US20050002950 Vaccine preventing infection
12/2004
12/30/2004DE10325752A1 Lektin-Konjugate Lectin conjugates
12/29/2004WO2004112572A2 Monitoring immunologic, hematologic and inflammatory diseases
12/29/2004EP1490085A2 Fc receptor homolog, reagents, and uses thereof
12/29/2004CA2529045A1 Monitoring immunologic, hematologic and inflammatory diseases
12/23/2004WO2004110390A2 Anti-cd74 immunoconjugates and methods
12/23/2004WO2004110367A2 Sdr proteins from staphylococcus capitis and their use in preventing and treating infections
12/23/2004US20040259768 Deactivable compound produced by target cell; diagnosis, therapy disease
12/23/2004CA2529496A1 Anti-cd74 immunoconjugates and methods
12/23/2004CA2526753A1 Sdr proteins from staphylococcus capitis and their use in preventing and treating infections
12/22/2004EP1487860A1 Compounds comprising pseudo-amino acids
12/21/2004CA2390358C Process for rapid solution synthesis of peptides
12/16/2004WO2004108751A1 A cardio myopeptidin, the production and the use thereof
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 48